Table 2.
Reduction of MADRS score from baseline to end of stimulation and after 3 months of follow-up after adjustment for potential confounding factors (ANCOVA).
| End of stimulation (T1) | 3-month follow-up (T2) | |||
|---|---|---|---|---|
| F | p | F | p | |
| Baseline MADRS score | 2.572 | 0.122 | 0.011 | 0.917 |
| Active TMS | 1.098 | 0.306 | 0.664 | 0.426 |
| Age | 0.121 | 0.732 | 0.047 | 0.832 |
| Education years | 0.244 | 0.626 | 0.342 | 0.566 |
| Sex (female) | 1.316 | 0.263 | 0.273 | 0.608 |
| MT % | 0.396 | 0.535 | 1.165 | 0.296 |
| TMS type (rTMS) | 0.417 | 0.525 | 1.604 | 0.222 |
| Coexisting personality disorder | 18.821 | <0.001 | 1.253 | 0.279 |
| Disease duration (years) | 0.533 | 0.473 | 1.851 | 0.191 |